DE2524882A1 - Mittel zur behandlung von hypercholesterinaemie - Google Patents

Mittel zur behandlung von hypercholesterinaemie

Info

Publication number
DE2524882A1
DE2524882A1 DE19752524882 DE2524882A DE2524882A1 DE 2524882 A1 DE2524882 A1 DE 2524882A1 DE 19752524882 DE19752524882 DE 19752524882 DE 2524882 A DE2524882 A DE 2524882A DE 2524882 A1 DE2524882 A1 DE 2524882A1
Authority
DE
Germany
Prior art keywords
agent according
pharmaceutical agent
compound
group
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752524882
Other languages
German (de)
English (en)
Inventor
Alan Norman Howard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE2524882A1 publication Critical patent/DE2524882A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE19752524882 1974-06-04 1975-06-04 Mittel zur behandlung von hypercholesterinaemie Withdrawn DE2524882A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24794/74A GB1501096A (en) 1974-06-04 1974-06-04 Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia

Publications (1)

Publication Number Publication Date
DE2524882A1 true DE2524882A1 (de) 1975-12-18

Family

ID=10217337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752524882 Withdrawn DE2524882A1 (de) 1974-06-04 1975-06-04 Mittel zur behandlung von hypercholesterinaemie

Country Status (17)

Country Link
US (1) US4041153A (en, 2012)
JP (1) JPS5112934A (en, 2012)
BE (1) BE829859A (en, 2012)
CA (1) CA1038291A (en, 2012)
DE (1) DE2524882A1 (en, 2012)
DK (1) DK248975A (en, 2012)
FI (1) FI751630A7 (en, 2012)
FR (1) FR2273517A1 (en, 2012)
GB (1) GB1501096A (en, 2012)
IE (1) IE41074B1 (en, 2012)
IL (1) IL47378A (en, 2012)
NL (1) NL7506609A (en, 2012)
NO (1) NO751973L (en, 2012)
NZ (1) NZ177627A (en, 2012)
PH (1) PH13199A (en, 2012)
SE (1) SE7506293L (en, 2012)
ZA (1) ZA753615B (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
FR2574295B1 (fr) * 1984-12-07 1988-02-26 Rech Etu Therapeutiques Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
US5025037A (en) * 1989-11-03 1991-06-18 Livingston William H Uses for the oral use of oak poison preventative in the treatment of: feline leukemia, increased wool production in sheep, and reduction of shipping fever in stressed animals
RU2157199C2 (ru) * 1998-04-03 2000-10-10 Вахрушев Яков Максимович Способ лечения хронического панкреатита
US20050106267A1 (en) 2003-10-20 2005-05-19 Framework Therapeutics, Llc Zeolite molecular sieves for the removal of toxins

Also Published As

Publication number Publication date
FR2273517A1 (fr) 1976-01-02
AU8159375A (en) 1976-12-02
IE41074B1 (en) 1979-10-10
CA1038291A (en) 1978-09-12
IL47378A0 (en) 1975-08-31
FR2273517B1 (en, 2012) 1978-10-06
BE829859A (fr) 1975-12-04
NZ177627A (en) 1978-04-03
JPS5112934A (en, 2012) 1976-01-31
PH13199A (en) 1980-01-28
NO751973L (en, 2012) 1975-12-05
US4041153A (en) 1977-08-09
DK248975A (da) 1975-12-05
SE7506293L (sv) 1975-12-05
FI751630A7 (en, 2012) 1975-12-05
IL47378A (en) 1978-06-15
GB1501096A (en) 1978-02-15
IE41074L (en) 1975-12-04
ZA753615B (en) 1977-02-23
NL7506609A (nl) 1975-12-08

Similar Documents

Publication Publication Date Title
DE60224052T2 (de) Aminpolymere zur behandlung von gicht und zur senkung des harnsäuregehaltes
DE69833134T2 (de) Verwendung aliphatischer amine zur verminderung von oxalat
DE69818058T2 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
EP0012804B1 (de) Salze eines zur dauernden Bindung an die Gallensäuren fähigen nicht toxischen aktivierten Anionenaustauscherharzes mit 2-(4'-(p-Chlorbenzoyl)-phenoxy)-2-(methyl)-propionsäure und diese Salze enthaltende Arzneimittel
DE60121016T2 (de) Polymere mizelle mit darin eingeschlossenem cisplatin und ihre verwendung
DE69511861T2 (de) Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür
EP0178436B1 (de) Ibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DE602004006892T2 (de) Anionenbindende polymere und ihre verwendungen
DE69907213T2 (de) Injektierbare formulierungen mit nanopartikulärem naproxen
DE69616791T2 (de) Zusammensetzungen und verfahren zum stabilisieren von polymeren
DE60106623T2 (de) Neue pharmazeutische zusammensetzung
DE69902046T2 (de) Neue feste dosisform enthaltend nanopartikelnaproxen
DE69923074T2 (de) Oral anzuwendendes rasch-freisetzendes arzneimittel enthaltend peptid-thrombinhemmer und eine mischung von mikrokristallinen zellulose und natrium stärke glycollaten
DE69812681T2 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60126433T2 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
AT398166B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE2524882A1 (de) Mittel zur behandlung von hypercholesterinaemie
DE69619979T2 (de) Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE69108022T3 (de) Arzneimittel.
DE60036830T2 (de) Verwendung von Polyethylenglykol zur Verminderung von Darmgasen, Krämpfen und Anorektalreizung
DE3834794C2 (en, 2012)
DE2636559A1 (de) Pharmazeutisches produkt
EP1509207A1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination